Skip to main content

Advertisement

Log in

Prevalence and significance of M541L single nucleotide polymorphism in the central European cohort of gastrointestinal stromal tumor patients

  • Original Article – Clinical Oncology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

Single nucleotide polymorphisms can create a genetic microenvironment in some tumors that affects the course of treatment, resistance, etc. Whether single nucleotide polymorphisms have an impact on gastrointestinal stromal tumor (GIST) development and disease progression is not yet accurately verified. KIT SNPM541L in exon 10 correlates with a worse prognosis of many cancers. The impact of KIT SNPM541L in GISTs is relatively unknown and, therefore, its analyses could have potential in patient therapy and could provide more detailed information on tumor character, clinical presentation, or tumor behavior in treatment.

Aim

The aim of the study was the analysis of the biological and clinical significance of the KIT SNPM541L polymorphism in exon 10.

Materials and methods

Paraffin sample tissues were obtained from the National GIST Register in Martin. Retrospective samples from 177 GIST patients were divided into several groups. Detection of SNPM541L was performed by Sanger sequencing. Statisitical analyses were performed to determine the prevalence of KIT SNPM541L in the Slovak GIST cohort, to search for correlation between c-KIT status and clinicopathological, molecular and biological data.

Results

Overall, 29 samples out of 177 showed KIT SNPM541L polymorphism.

Conclusion

Our results do not support the association between KIT SNPM541L and increased risk of relapse in localized primary GISTs. Additionally, we found a positive correlation between KIT SNPM541L occurrence and earlier onset of relapse in PDGFRa and WT subgroup of GISTs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Alvi MA, Loughrey MB, Dunne P, McQuaid S, Turkington R, Fuchs MA, McGready C, Bingham V, Pang B, Moore W, Maxwell P, Lawler M, James JA, Murray GI, Wilson RH, Salto-Tellez M et al (2017) Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies. Br J Cancer 117:203–209

    Article  CAS  Google Scholar 

  • Angelini S, Ravegnini G, Nannini M, Bermejo JL, Musti M, Pantaleo MA, Fumagalli E, Venturoli N, Palassini E, Consolini N, Casali PG, Biasco G, Hrelia P (2015) Folate-related polymorphisms in gastrointestinal stromal tumours: susceptibility and correlation with tumour characteristics and clinical outcome. Eur J Hum Genet 23:817–823

    Article  CAS  Google Scholar 

  • Barbano R, Pasculli B, Coco M, Fontana A, Copetti M, Rendina M, Valori VM, Graziano P, Maiello E, Fazio VM, Parrella P (2015) Competitive allele-specific TaqMan PCR (Cast-PCR) is a sensitive, specific and fast method for BRAF V600 mutation detection in Melanoma patients. Sci Rep 5:18592

    Article  CAS  Google Scholar 

  • Brahmi M, Alberti L, Dufresne A, Ray-Coquard I, Cassier P, Meeus P, Decouvelaere AV, Ranchère-Vince D, Blay JP (2015) KIT exon 10 variant (c.1621 A > C) single nucleotide polymorphism as predictor of GIST patient outcome. BMC Cancer 15:780

    Article  Google Scholar 

  • Chevrier S, Arnould L, Ghiringhelli F, Coudert B, Fumoleau P, Boidot R (2014) Next-generation sequencing analysis of lung and colon carcinomas reveals a variety of genetic alterations. Int J Oncol 45:1167–1174

    Article  CAS  Google Scholar 

  • Deng N, Zhou H, Fan H, Yuan Y (2017) Single nucleotide polymorphisms and cancer susceptibility. Oncotarget 8:110635–110649

    Article  Google Scholar 

  • Dufresne A, Alberti L, Brahmi M, Kabani S, Philippon H, Pérol D, Blay JY (2014) Impact of KIT exon 10 M541L allelic variant on the response to imatinib in aggressive fibromatosis: analysis of the desminib series by competitive allele specific Taqman PCR technology. BMC Cancer 14:632

    Article  Google Scholar 

  • Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley J, Miettinen M, O'Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW (2002) Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 33:459–465

    Article  Google Scholar 

  • Foster R, Byrnes E, Meldrum C, Griffith R, Ross G, Upjohn E, Braue A, Scott R, Varigos G, Ferrao P, Ashman LK (2008) Association of paediatric mastocytosis with a polymorphism resulting in an amino acid substitution (M541L) in the transmembrane domain of c-KIT. Br J Dermatol 159:1160–1169

    CAS  PubMed  Google Scholar 

  • Ghagane S, Nerli RB, Kaliwal BB, Hiremath MB (2016) Single nucleotide polymorphisms: a new paradigm in predicting the risk of prostate cancer. Cell Dev Biol 5:1000168

    Article  Google Scholar 

  • Grabellus F, Worm K, Sheu SY, Siffert W, Schmid KW, Bachmann HS (2011) The prevalence of the c-kit exon 10 variant, M541L, in aggressive fibromatosis does not differ from the general population. J Clin Pathol 64:1021–1024

    Article  CAS  Google Scholar 

  • Hoade Y, Metzgeroth G, Schwaab J, Reiter A, Cross NCP (2018) Routine Screening for KIT M541L Is Not Warranted in the Diagnostic Work-Up of Patients with Hypereosinophilia. Acta Haematol 139:71–73

    Article  CAS  Google Scholar 

  • Hurley RH, McCormick M, Elhassan M, Nicholson G (2018) Gastrointestinal stromal tumour as a rare association with neurofibromatosis type 1. J Surg Case Rep 2:2

    Google Scholar 

  • Huss S, Künstlinger H, Wardelmann E, Kleine MA, Binot E, Merkelbach-Bruse S, Rüdiger T, Mittler J, Hartmann W, Büttner R, Schildhaus HU (2013) A subset of gastrointestinal stromal tumors previously regarded as wild-type tumors carries somatic activating mutations in KIT exon 8 (p. D419del). Mod Pathol 26:1004–1012

    Article  CAS  Google Scholar 

  • Inokuchi K, Yamaguchi H, Tarusawa M, Futaki M, Hanawa H, Tanosaki S, Dan K (2002) Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia–potential clinical significance. Leukemia 16:170–177

    Article  CAS  Google Scholar 

  • Ito T, Yamamura M, Hirai T, Ishikawa T, Kanda T, Nakai T, Ohkouchi M, Hashikura Y, Isozaki K, Hirota S (2014) Gastrointestinal stromal tumors with exon 8 c-kit gene mutation might occur at extragastric sites and have metastasis-prone nature. Int J Clin Exp Pathol 7:8024–8031

    PubMed  PubMed Central  Google Scholar 

  • Iurlo A, Gianelli U, Beghini A, Spinelli O, Orofino N, Lazzaroni F, Cambiaghi S, Intermesoli T, Rambaldi A, Cortelezzi A (2014) Identification of kit (M541L) somatic mutation in chronic eosinophilic leukemia, not otherwise specified and its implication in low-dose imatinib response. Oncotarget 4665–4670.

  • Jasek K, Buzalkova V, Minarik G, Stanclova A, Szepe P, Plank L, Lasabova Z (2017) Detection of mutations in the BRAF gene in patients with KIT and PDGFRA wild-type gastrointestinal stromal tumors. Virchows Arch 470:29–36

    Article  CAS  Google Scholar 

  • Ke H, Kazi JU, Zhao H, Sun J (2016) Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis. Cell Biosci 6:55

    Article  Google Scholar 

  • Krasagakis K, Metaxari M, Zervou M, Stathopoulos EN, Eberle J, Kanitakis J, Georgoulias V, Krüger-Krasagakis S, Tavernarakis N, Tosca AD (2011) Identification of the M541L sequence variation of the transmembrane KIT domain in Merkel cell carcinoma. Anticancer Res 31:807–811

    CAS  PubMed  Google Scholar 

  • Krüger S, Emig M, Lohse P, Ehninger G, Hochhaus A, Schackert HK (2006) The c-kit (CD117) sequence variation M541L, but not N564K, is frequent in the general population, and is not associated with CML in Caucasians. Leukemia 20:354–355

    Article  Google Scholar 

  • Lasota J, Felisiak-Golabek A, Wasag B, Kowalik A, Zięba S, Chłopek M, Wang ZF, Coates T, Kopczynski J, Gozdz S, Sarlomo-Rikala M, Miettinen M (2016) Frequency and clinicopathologic profile of PIK3CA mutant GISTs: molecular genetic study of 529 cases. Mod Pathol 29:275–282

    Article  CAS  Google Scholar 

  • Laytragoon-Lewin N, Cederblad L, Andersson BÅ, Olin M, Nilsson M, Rutqvist LE, Lundgren J, Engström M, Tytor W, Löfgren S, Lewin F (2017) Single-nucleotide polymorphisms and cancer risk, tumor recurrence, or survival of head and neck cancer patients. Oncology 92:161–169

    Article  CAS  Google Scholar 

  • Li K, Cheng H, Li Z, Pang Y, Jia X, Xie F, Hu G, Cai Q, Wang Y (2017) Genetic progression in gastrointestinal stromal tumors: mechanisms and molecular interventions. Oncotarget 8:60589–60604

    Article  Google Scholar 

  • Masago K, Fujita S, Muraki M, Hata A, Okuda C, Otsuka K, Kaji R, Takeshita J, Kato R, Katakami N, Hirata Y (2015) Next-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutations. BMC Cancer 15:908

    Article  Google Scholar 

  • Miettinen M, Lasota J (2006) Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol 23:70–83

    Article  Google Scholar 

  • Minarik G, Plank L, Lasabova Z, Szemes T, Burjanivova T, Szepe P, Buzalkova V, Porubsky D, Sufliarsky J (2013) Spectrum of mutations in gastrointestinal stromal tumor patients—a population based study from Slovakia. APMIS 121:539–548

    Article  CAS  Google Scholar 

  • Nannini M, Astolfi A, Urbini M, Indio V, Santini D, Heinrich MC, Corless CL, Ceccarelli C, Saponara M, Mandrioli A, Lolli C, Ercolani G, Brandi G, Biasco G, Pantaleo MA (2014) Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST). BMC Cancer 14:685

    Article  Google Scholar 

  • Niinuma T, Suzuki H, Sugai T (2018) Molecular characterization and pathogenesis of gastrointestinal stromal tumor. Transl Gastroenterol Hepatol 9:3

    Google Scholar 

  • Noujaim J, Gonzalez D, Thway K, Jones RL, Judson J (2016) p. (L576P) -KIT mutation in GIST: favorable prognosis and sensitive to imatinib? Cancer Biol Ther 17:543–545

    Article  CAS  Google Scholar 

  • O’Brien KM, Orlow I, Antonescu CR, Ballman K, McCall L, DeMatteo R, Engel LS (2013a) Gastrointestinal stromal tumors, somatic mutations and candidate genetic risk variants. PLoS ONE 8:e62119

    Article  Google Scholar 

  • O’Brien KM, Orlow I, Antonescu CR, Ballman K, McCall L, DeMatteo R, Engel LS (2013b) Gastrointestinal stromal tumors: a case-only analysis of single nucleotide polymorphisms and somatic mutations. Clin Sarcoma Res 3:12

    Article  Google Scholar 

  • Péčová T, Vorčáková K, Žaliová M, Burjanivová T, Malicherová B, Plank L, Trka J, Péčová K, Adamicová K, Péč M, Pec J (2018) Testicular cancer in monozygotic twin brothers with urticaria pigmentosa. Acta Derm Venereol 98:528–529

    Article  Google Scholar 

  • Pedersen M, Rönnstrand L, Sun J (2009) The c-Kit/D816V mutation eliminates the differences in signal transduction and biological responses between two isoforms of c-Kit. Cell Signal 21:413–418

    Article  CAS  Google Scholar 

  • Plank L, Buzalkova V, Szepe P, Lasabova Z, Jasek K, Stanclova A, Minarik G, Sufliarsky J (2017) Gastrointestinal stromal tumor after tyrosine kinase inhibition therapy: a review of biopsies of 34 patients with clinically suspected relapse and/or progression of the tumor. Neoplasma 64:464–473

    Article  CAS  Google Scholar 

  • Quek R, George S (2010) Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib. Biologics 4:19–31

    CAS  PubMed  PubMed Central  Google Scholar 

  • Rocha J, Luz Duarte M, Marques H, Torres F, Tavares P, Silva A, Brito C (2010) Association of adult mastocytosis with M541L in the transmembrane domain of KIT. J Eur Acad Dermatol Venereol 24:1118–1119

    CAS  PubMed  Google Scholar 

Download references

Funding

This publication is the result of the project implementation: “CENTER OF EXCELLENCE FOR RESEARCH IN PERSONALIZED THERAPY (CEVYPET)”, ITMS: 26220120053 supported by the Operational Programme Research and Innovation funded by the ERDF. This study was also supported by the project of Slovak Research and Development Agency no. APVV-16-0066 as well as by the Grant of The Ministry of Education, Science, Research and Sport of the Slovak Republic no.VEGA-1/0380/18.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Peter Kruzliak or Zora Lasabova.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Research involving human participants and/or animals

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jasek, K., Grendar, M., Stanclova, A. et al. Prevalence and significance of M541L single nucleotide polymorphism in the central European cohort of gastrointestinal stromal tumor patients. J Cancer Res Clin Oncol 147, 1203–1215 (2021). https://doi.org/10.1007/s00432-020-03410-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-020-03410-8

Keywords

Navigation